Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy

Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is one of the well-recognized extranodal lymphomas commonly addicted to the B-cell receptor-MYD88 superpathway. We aimed to describe the genomic changes in a patient who progressed through treatment with ibrutinib, a Bruton&r...

Full description

Bibliographic Details
Main Authors: Lucy C. Fox, Costas K. Yannakou, Georgina Ryland, Stephen Lade, Michael Dickinson, Belinda A. Campbell, Henry Miles Prince
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:International Journal of Molecular Sciences
Subjects:
primary cutaneous diffuse large B-cell lymphoma, leg type
ibrutinib
Online Access:http://www.mdpi.com/1422-0067/19/6/1758

Internet

http://www.mdpi.com/1422-0067/19/6/1758

Similar Items